All Articles tagged tyrosine kinase inhibitors
- Oncology
August 04, 2022 EDT Treatment patterns, healthcare resource utilization, and costs were evaluated among patients with chronic myeloid leukemia who received third or later lines of therapy.
- Oncology
April 27, 2015 EDT Research has shown that treatment interruptions are associated with worse failure-free survival in chronic myeloid leukemia (CML); however they are commonly used in clinical trials to manage adverse events.